HomeADPT β’ NASDAQ
add
Adaptive Biotechnologies Corp
Previous close
$15.58
Day range
$15.92 - $16.95
Year range
$4.27 - $16.95
Market cap
2.57B USD
Avg Volume
1.96M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 58.88M | 36.33% |
Operating expense | 41.78M | 8.15% |
Net income | -25.61M | 44.58% |
Net profit margin | -43.50 | 59.35% |
Earnings per share | -0.17 | 41.50% |
EBITDA | -20.53M | 41.52% |
Effective tax rate | β | β |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 197.87M | -32.21% |
Total assets | 496.64M | -15.09% |
Total liabilities | 317.10M | -7.67% |
Total equity | 179.54M | β |
Shares outstanding | 152.27M | β |
Price to book | 13.20 | β |
Return on assets | -12.42% | β |
Return on capital | -15.49% | β |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -25.61M | 44.58% |
Cash from operations | -12.43M | 28.16% |
Cash from investing | 3.35M | -43.07% |
Cash from financing | 1.61M | 5,266.67% |
Net change in cash | -7.47M | 34.42% |
Free cash flow | 2.58M | 3,696.51% |
About
CEO
Founded
2009
Headquarters
Website
Employees
619
